(Q37597243)

21 August 2017

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene (English)

1 reference

21 August 2017

acute myeloid leukemia

1 reference

Valentina Indio

6

0 references

Annalisa Lonetti

Annalisa Lonetti

5

0 references

Annalisa Astolfi

Annalisa Astolfi

3

0 references

Andrea Pession

Andrea Pession

15

0 references

Martina Pigazzi

Martina Pigazzi

11

0 references

Franco Locatelli

14

Franco Locatelli

1 reference

21 August 2017

13

Giuseppe Basso

1 reference

21 August 2017

4

Francesca Chiarini

1 reference

21 August 2017

12

Alberto Maria Martelli

1 reference

21 August 2017

9

Salvatore Serravalle

1 reference

21 August 2017

10

Monica Franzoni

1 reference

21 August 2017

Riccardo Masetti

1

1 reference

21 August 2017

Salvatore Nicola Bertuccio

2

1 reference

21 August 2017

Matilde De Luca

7

1 reference

21 August 2017

Jessica Bandini

8

1 reference

21 August 2017

21 January 2017

1 reference

Journal of Hematology & Oncology

21 August 2017

1 reference

21 August 2017

10

1 reference

21 August 2017

1

1 reference

21 August 2017

26

1 reference

https://scigraph.springernature.com/pub.10.1186/s13045-017-0396-0

21 August 2017

0 references

cites work

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5251306

10.1186/S13045-017-0396-0

1 September 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference

21 August 2017

1 reference